Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Mewton

Showing results (71-80 of 186) with videos related to

Pageof 19
Sort By:
Frontiers in Pediatrics|July 23, 2024
Celsior® vs. St Thomas® cardioplegia: analysis of myocardial protection and clinical safety in neonatesNicolae Cristian Bulescu, Julia Mitchell, Olivier Metton, et al.
The American Journal of Cardiology|January 2, 2018
Effect of Optimal Medical Therapy at Discharge in Patients With Reperfused ST-Segment Elevation Myocardial Infarction on 1-Year Mortality (from the Regional RESCUe Registry)Danka Tomasevic, Carlos El Khoury, Fabien Subtil, et al.
JACC. Basic to Translational Science|July 10, 2024
Soluble Programmed Death-1 Predicts Clinical Outcome After STEMIAhmad Hayek, Camille Brun, Simon Leboube, et al.
Heart Rhythm|August 26, 2024
SEMA3A as a biomarker of primary ventricular fibrillation complicating STEMIClément Boiteux, Simon Leboube, Ahmad Hayek, et al.
Journal of the American College of Cardiology|May 7, 2021
Soluble C-Met as a Biomarker of Clinical Outcomes After STEMISimon Leboube, Alexandre Paccalet, Claire Crola Da Silva, et al.
Journal of the American College of Cardiology|January 11, 2020
Heat Shock Protein 70 as a Biomarker of Clinical Outcomes After STEMIThomas Bochaton, Alexandre Paccalet, Pierre Jeantet, et al.
The American Journal of Cardiology|July 23, 2013
Therapeutic management changes and mortality rates over 30 years in ventricular septal rupture complicating acute myocardial infarctionSophie Morillon-Lutun, Delphine Maucort-Boulch, Nathan Mewton, et al.
Basic Research in Cardiology|December 14, 2019
Importance of infarct size versus other variables for clinical outcomes after PPCI in STEMI patientsThomas Bochaton, Marc J Claeys, David Garcia-Dorado, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 1, 2011
T2-weighted cardiac MR assessment of the myocardial area-at-risk and salvage area in acute reperfused myocardial infarction: comparison of state-of-the-art dark blood and bright blood T2-weighted sequencesMagalie Viallon, Nathan Mewton, Franck Thuny, et al.
Current Neurovascular Research|June 28, 2019
Impact of Collateral Status on Neuroprotective Effect of Cyclosporine A in Acute Ischemic StrokeNorbert Nighoghossian, Lucie Cornut, Camille Amaz, et al.
Pageof 19

Showing results (71-80 of 186) with videos related to

Sort By:
Pageof 19
Frontiers in Pediatrics|July 23, 2024
Celsior® vs. St Thomas® cardioplegia: analysis of myocardial protection and clinical safety in neonatesNicolae Cristian Bulescu, Julia Mitchell, Olivier Metton, et al.
The American Journal of Cardiology|January 2, 2018
Effect of Optimal Medical Therapy at Discharge in Patients With Reperfused ST-Segment Elevation Myocardial Infarction on 1-Year Mortality (from the Regional RESCUe Registry)Danka Tomasevic, Carlos El Khoury, Fabien Subtil, et al.
JACC. Basic to Translational Science|July 10, 2024
Soluble Programmed Death-1 Predicts Clinical Outcome After STEMIAhmad Hayek, Camille Brun, Simon Leboube, et al.
Heart Rhythm|August 26, 2024
SEMA3A as a biomarker of primary ventricular fibrillation complicating STEMIClément Boiteux, Simon Leboube, Ahmad Hayek, et al.
Journal of the American College of Cardiology|May 7, 2021
Soluble C-Met as a Biomarker of Clinical Outcomes After STEMISimon Leboube, Alexandre Paccalet, Claire Crola Da Silva, et al.
Journal of the American College of Cardiology|January 11, 2020
Heat Shock Protein 70 as a Biomarker of Clinical Outcomes After STEMIThomas Bochaton, Alexandre Paccalet, Pierre Jeantet, et al.
The American Journal of Cardiology|July 23, 2013
Therapeutic management changes and mortality rates over 30 years in ventricular septal rupture complicating acute myocardial infarctionSophie Morillon-Lutun, Delphine Maucort-Boulch, Nathan Mewton, et al.
Basic Research in Cardiology|December 14, 2019
Importance of infarct size versus other variables for clinical outcomes after PPCI in STEMI patientsThomas Bochaton, Marc J Claeys, David Garcia-Dorado, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 1, 2011
T2-weighted cardiac MR assessment of the myocardial area-at-risk and salvage area in acute reperfused myocardial infarction: comparison of state-of-the-art dark blood and bright blood T2-weighted sequencesMagalie Viallon, Nathan Mewton, Franck Thuny, et al.
Current Neurovascular Research|June 28, 2019
Impact of Collateral Status on Neuroprotective Effect of Cyclosporine A in Acute Ischemic StrokeNorbert Nighoghossian, Lucie Cornut, Camille Amaz, et al.
Pageof 19